The operational and trading companion to the Private Credit Drawdown thesis (Vol. II). A complete desk manual for the $3T combined leveraged loan and high-yield bond market — settlement mechanics, credit agreement anatomy, the 15 most common LME structures, 10 actionable trading strategies, and the full instrument toolkit from CDX indices to loan ETFs.
The operational mechanics of trading leveraged loans and high-yield bonds. How loans settle (T+7 via LSTA vs. T+1 for bonds). Assignment vs. participation. Credit agreement anatomy — covenants, EBITDA adjustments, restricted payments baskets. The full index and ETF toolkit. 10 desk-ready strategies with entry/exit triggers. The LME playbook that defines modern credit restructuring.
Rising defaults are activating LME activity at unprecedented scale. Every major restructuring in 2025-2026 has used at least one aggressive creditor-on-creditor violence maneuver. If you cannot identify an uptier priming transaction, a drop-down, or a double-dip structure before it closes, you will be the creditor left holding impaired paper. This is no longer optional knowledge — it is survival literacy.
Vol. II (Private Credit Drawdown) provides the strategic thesis: why credit stress is building, which sectors are vulnerable, and the macro framework for positioning. This volume (Vol. X) is the operational companion — HOW to execute. Vol. II says "short credit." This volume tells you which CDX series to sell, what basis to capture, and how to structure the trade with exact settlement mechanics.
Credit traders, portfolio managers, CLO analysts (cross-ref Vol. III), distressed investors (cross-ref Vol. IV), and anyone who needs to understand the plumbing of leveraged credit. If you trade loans, bonds, CDX, or CLOs — or if you manage a portfolio that holds them — this is your desk reference. The LME section alone justifies the read for any credit professional.
The leveraged loan market settles T+7, trades by appointment in a dealer market, and is governed by 300-page credit agreements filled with exploitable ambiguity. The HY bond market settles T+1, trades electronically, and is governed by trust indentures with covenant packages that range from "iron-clad" to "swiss cheese." Knowing the mechanics is not academic — it is the difference between capturing 200bps of basis and being the last one holding paper in an LME you didn't see coming.
Real-time pulse of the $3T leveraged credit market. These are the six numbers every credit desk watches before the open. When they move in concert, a regime change is underway.
| Metric | Current | 1Y Ago | 5Y Avg | Stress Level | Signal |
|---|---|---|---|---|---|
| LTM Default Rate (Loans) | ~3.0% | 2.1% | 2.8% | Elevated | Rising — highest since 2020 |
| LTM Default Rate (HY Bonds) | 1.44% | 1.9% | 2.5% | Elevated | Accelerating from H2 2025 |
| Distress Ratio (Loans <80) | 8.7% | 3.2% | 4.5% | High | Pipeline for future defaults |
| New Issue Volume (YTD) | $89B | $142B | $118B | Reduced | Primary market tightening |
| CLO Formation (YTD) | $31B | $52B | $44B | Below avg | Demand side weakening |
| BB-CCC Spread | 582 bps | 340 bps | 380 bps | Wide | Quality bifurcation extreme |
| Avg Recovery Rate (1st Lien) | 62% | 68% | 65% | Below avg | LME activity compressing recoveries |
| Avg Recovery Rate (Sr. Unsec.) | 28% | 38% | 35% | Low | Creditor-on-creditor violence impact |
The BB-CCC spread at 582 bps is the single most important number on this dashboard. The long-run average is ~380 bps. At 582 bps, the market is telling you that lower-quality credits are being aggressively repriced while BBs remain relatively well-bid (CLO demand, fallen angel flows). When BB-CCC exceeds 500 bps, it historically signals: (1) dispersion is the dominant strategy over beta, (2) CCC names are pricing for restructuring, not recovery, and (3) the compression trade (long CCC / short BB) becomes viable once the spread peaks. Vol. II Strategy 04 and this volume's Strategy 10 are both activated at these levels.
Recovery rate compression is the hidden story of 2025-2026. First-lien recovery rates have fallen from a historical 65% average to 62% — but the real damage is in senior unsecured, where LME activity (uptier priming, drop-downs) has stripped value from previously pari passu creditors. A senior unsecured bondholder who expected 38 cents is recovering 28 cents. The LME playbook in Section 06 explains exactly how this value transfer works.
Leveraged loans and high-yield bonds finance the same companies but through radically different structures. Every difference creates a tradeable inefficiency. Master the architecture and you see the basis trades.
| Feature | Leveraged Loans | High-Yield Bonds | Why It Matters |
|---|---|---|---|
| Market Size | $1.4T outstanding | $1.6T outstanding | Combined $3T — largest sub-IG market |
| Rate Structure | Floating (SOFR + spread) | Fixed coupon | Duration risk sits entirely in bonds |
| Seniority | Senior secured (1st lien) | Senior unsecured (typically) | Loans recover 60-65%; bonds 35-40% |
| Settlement | T+7 (LSTA standard) | T+1 (DTC) | Loan settlement risk is 7x longer |
| Trading Venue | Dealer market (by appointment) | TRACE-reported, increasingly electronic | Loan pricing is less transparent |
| Documentation | Credit agreement (300+ pages) | Trust indenture (150+ pages) | Loan docs are more negotiated/flexible |
| Call Protection | Typically 101 soft call for 6 months | NC/2-3 years, then declining premium | Loans can be repriced at any time |
| Covenants | Maintenance (quarterly test) or Cov-Lite | Incurrence only | Loans historically had tighter controls |
| Primary Buyer | CLOs (65-70% of demand) | Mutual funds, insurance, pensions | CLO health drives loan pricing |
| Minimum Denomination | $1M face (typically) | $1,000-$2,000 face | Loans are institutional-only |
| Prepayment | At par (after soft call) | Make-whole or premium schedule | Loan upside capped near par |
| Transfer Mechanism | Assignment or participation | DTC book-entry transfer | Loan transfers are complex & slow |
The credit agreement is the constitution of the loan. Every LME exploit, every basis trade, every restructuring hinges on what the credit agreement allows. Key sections that matter:
1. EBITDA Adjustments (Section: Definitions): "Adjusted EBITDA" can include pro-forma synergies, cost savings, run-rate revenue, and add-backs that inflate reported leverage by 1-2 turns. A company reporting 4.5x leverage on adjusted EBITDA may be 6.5x on cash EBITDA. Always ask: "What are the add-backs?"
2. Restricted Payments Basket (Section: Negative Covenants): Governs dividends, share buybacks, and transfers to unrestricted subsidiaries. The "builder basket" allows distributions based on cumulative excess cash flow. Aggressive sponsors use this to extract value before restructuring.
3. Permitted Investments & Unrestricted Subsidiaries: The gateway to drop-down transactions. If the credit agreement permits the borrower to designate subsidiaries as "unrestricted," assets can be moved beyond the reach of existing creditors. J.Crew used this to move its IP. Serta used it to prime existing lenders.
4. Pro Rata Sharing (Section: Payments): Determines whether all lenders must be treated equally. Exceptions to pro-rata sharing enable the "non-pro-rata exchange" LME — the most contentious structure in modern credit.
5. Amendment Threshold (Section: Amendments): Typically requires simple majority (50.1%) for most amendments, but sacred rights (payment terms, collateral release, pro-rata sharing) require 100% or supermajority consent. If you hold a blocking position (>50.1% or the relevant threshold), you control the restructuring.
| Feature | Assignment | Participation |
|---|---|---|
| Legal Status | Buyer becomes lender of record | Buyer has economic interest only |
| Voting Rights | Full voting rights | No direct vote — granted by seller |
| Agent Consent | Typically required (can be unreasonably withheld) | Not required |
| Settlement Time | T+7 to T+20 (with consent delays) | T+3 to T+7 |
| Counterparty Risk | Direct claim on borrower | Exposed to seller's credit risk |
| Use Case | Standard for institutional trades | When speed matters or consent is blocked |
Cov-Lite dominance has changed the game. As of 2026, approximately 90% of outstanding leveraged loans are "covenant-lite" — meaning they have incurrence-based covenants (tested only when the borrower takes an action) rather than maintenance covenants (tested quarterly). This means a company can deteriorate for quarters without triggering a technical default. The practical impact: by the time a cov-lite loan defaults, it has already lost more value than a maintenance-covenant loan would have, because early intervention (amend & extend, forced asset sales) was not triggered. Cov-lite loans have recovery rates approximately 5-8 percentage points lower than maintenance-covenant loans.
Every tradeable instrument in the leveraged credit universe — from broad indices to single-name CDS, from loan ETFs to HY futures. Know your instruments and you can express any credit view with precision.
| Index | Underlier | Composition | Roll | Use Case | Current Level |
|---|---|---|---|---|---|
| LSTA 100 | 100 largest leveraged loans | Loan-only, SOFR-based, 1st lien | Monthly rebalance | Benchmark for loan portfolio returns | 96.2 (avg price) |
| CDX HY | 100 liquid HY CDS names | Sub-IG single-name CDS basket | Semi-annual (Mar/Sep) | Macro HY short/long, basis trades | 412 bps (Series 43) |
| CDX IG | 125 liquid IG CDS names | IG single-name CDS basket | Semi-annual (Mar/Sep) | IG hedge, crossover trades | 62 bps (Series 43) |
| CDX HY 0-1 (HY35) | CDX HY subordinate tranche | 0-3% equity tranche of CDX HY | Follows CDX HY roll | Levered HY exposure, correlation trade | Upfront 38pts |
| iTraxx Crossover | 75 European sub-IG names | European HY CDS basket | Semi-annual (Mar/Sep) | European HY hedge, basis vs CDX HY | 385 bps |
| LCDX | 100 liquid loan CDS names | Loan-only CDS basket | Semi-annual | Loan-specific macro hedge (low liquidity) | Limited trading |
CDX HY roll dynamics: The CDX HY index rolls every six months (March 20 and September 20). During the roll, names that have migrated to IG or defaulted are removed, and new qualifying names are added. The "on-the-run" (newest) series is always the most liquid. The "off-the-run" series trades at a basis to on-the-run — this basis itself is tradeable. The roll creates a systematic selling opportunity: dealers who are long protection on the old series and need to roll into the new series create temporary supply/demand imbalances. Historically, buying protection 2 weeks before the roll and selling after captures 5-15 bps.
| Ticker | Name | AUM | Expense | Yield | Focus | Liquidity | Key Feature |
|---|---|---|---|---|---|---|---|
| BKLN | Invesco Sr. Loan ETF | $5.4B | 0.65% | 8.2% | Senior loans (floating) | $45M/day | Largest loan ETF; NAV discount in stress |
| SRLN | SPDR Blackstone Sr. Loan | $4.1B | 0.70% | 8.5% | Senior loans (active mgmt) | $35M/day | Actively managed — Blackstone selects |
| HYG | iShares iBoxx HY Corp Bond | $14.8B | 0.49% | 7.1% | HY corporate bonds | $1.2B/day | Most liquid HY vehicle; options chain |
| JNK | SPDR Bloomberg HY Bond | $7.2B | 0.40% | 7.3% | HY corporate bonds | $520M/day | Lower cost; slightly different index |
| ANGL | VanEck Fallen Angel HY Bond | $2.8B | 0.35% | 6.8% | Fallen angels (IG→HY downgrades) | $28M/day | Higher quality HY; fallen angel premium |
| HYDB | iShares HY Bond Factor | $0.9B | 0.35% | 7.0% | Multi-factor HY screen | $8M/day | Factor-based approach to HY |
| USHY | iShares Broad USD HY Corp | $10.1B | 0.15% | 4.1% | Broad HY (low cost) | $280M/day | Lowest cost HY exposure |
The HYG-CDX HY basis trade is the most important instrument relationship to understand. HYG (the ETF) tracks a cash bond index. CDX HY (the CDS index) tracks synthetic credit spreads. In normal markets they move together. In stress, HYG trades at a discount to NAV (forced selling by retail) while CDX HY widens faster (institutional hedging). The basis between these two is Strategy 01 in this manual. In March 2020, the HYG-CDX HY basis blew out to 150+ bps before the Fed intervened. That basis trade returned 8-12% in 6 weeks.
| Instrument | Exchange | Contract | Use Case |
|---|---|---|---|
| CDX HY Options | OTC / ICE | Options on CDX HY index spread | Tail risk hedging, volatility expression |
| HYG Options | CBOE | Listed options on HYG ETF | Most liquid HY options chain available |
| JNK Options | CBOE | Listed options on JNK ETF | Alternative to HYG for spread plays |
| BKLN Options | CBOE | Listed options on BKLN ETF (limited) | Loan-specific downside hedges |
| US HY Total Return Futures | CME | ICE BofA HY Index futures | Duration-hedged HY exposure |
The plumbing of leveraged credit trading. Settlement risk, bid/ask dynamics, and the difference between mark-to-market and mark-to-model. Getting the mechanics wrong costs real money.
| Parameter | Leveraged Loans | HY Bonds | CDX (CDS Index) |
|---|---|---|---|
| Standard Settlement | T+7 (LSTA par/near-par) T+10-20 (distressed) | T+1 (DTC) | T+3 (DTCC) |
| Settlement Agent | LSTA / agent bank | DTC / clearing bank | ICE Clear Credit / DTCC |
| Accrued Interest | Calculated on actual/360 | 30/360 or actual/actual | Quarterly premium payments |
| Failed Trade Handling | DK (Don't Know) process; buyout/sellout rights | NSCC CNS system | Cash settlement at determination committee |
| Documentation Required | Assignment agreement or participation agreement | None (book-entry) | ISDA Master + Credit Support Annex |
| KYC / AML | Agent bank may require KYC on new assignee | None post-trade | Clearing member handles |
| Delay Risk | High — agent consent, KYC, document execution | Low | Low |
Loan settlement delay is a real P&L risk. The T+7 standard is aspirational — actual settlement can take 14-20+ business days for distressed or complex trades. During this delay: (1) the buyer bears market risk without being the lender of record, (2) the seller continues receiving interest payments they will owe to the buyer, (3) credit events (default, LME announcement) can occur between trade date and settlement date, creating disputes. In March 2020, average loan settlement times stretched to T+22. Trades agreed at 85 settled when the loan was at 70. Always price settlement delay risk into distressed loan purchases.
| Market Segment | Typical Bid/Ask | Market Makers | Price Discovery |
|---|---|---|---|
| Performing Loans (par) | 25-50 bps | 10-15 dealers | LSTA/LPC marks, dealer runs |
| Performing Loans (discount) | 50-150 bps | 8-12 dealers | Dealer axes, BWIC/OWIC |
| Distressed Loans (<80) | 200-500 bps | 5-8 specialist dealers | BWIC/OWIC, direct negotiation |
| HY Bonds (BB-rated) | 25-50 bps | 15-20 dealers | TRACE, MarketAxess, Bloomberg |
| HY Bonds (CCC-rated) | 100-300 bps | 8-12 dealers | TRACE (delayed), dealer runs |
| CDX HY Index | 2-5 bps | 12-15 dealers | Screen-based, SEF |
Mark-to-market vs. mark-to-model: HY bonds have TRACE transparency — every trade is reported. Loans do not. Loan marks are typically based on: (1) dealer consensus pricing services (Markit, LSTA), (2) actual trade levels (sparse), (3) model-based marks by the holder. This means loan portfolios (CLOs, BDCs, loan mutual funds) can carry stale marks for weeks. When a loan trades at 72 but a CLO is marking it at 85, the CLO's NAV is overstated by 13 points on that position. Vol. III (CLO Deep Dive) discusses how this affects CLO equity returns and OC test calculations. The liquidity illusion in loans is one of the most persistent mispricings in credit markets.
BWIC (Bids Wanted in Competition) and OWIC (Offers Wanted in Competition) are the primary price discovery mechanisms for loans and less liquid bonds. A seller circulates a BWIC list to 5-15 dealers, who submit sealed bids by a deadline (typically 11am ET). The seller can accept the best bid, counter, or reject. BWIC flow is the most important leading indicator of forced selling. When CLOs breach OC tests (Vol. III), they must sell CCC-rated loans via BWICs — this creates predictable downward pressure. Tracking BWIC volumes by rating category is a leading indicator of CLO stress. Conversely, when you see BWICs drying up, the selling pressure is abating.
Ten desk-ready strategies for leveraged credit markets. Each includes the thesis, instruments, entry/exit triggers, and cross-references to the broader series. Ordered from lowest to highest complexity.
| # | Strategy | Instruments | Thesis | Expected Return | Complexity |
|---|---|---|---|---|---|
| S01 | CDX HY Basis Trade | CDX HY + HYG/JNK | CDX widens faster than cash in stress; buy cash / sell CDX at wide basis | 150-400 bps | Moderate |
| S02 | Loan-Bond Basis Arb | Same-issuer loan + bond | Loan and bond of same issuer diverge; arb the spread to fundamental value | 100-300 bps | Moderate |
| S03 | Fallen Angel Rotation | ANGL ETF + single names | IG→HY downgrades are force-sold by IG funds; buy the dislocation, sell after stabilization | 200-500 bps | Low |
| S04 | New Issue Concession Capture | Primary market + secondary | New HY issues price at 25-50 bps concession; buy primary, sell secondary after the break | 50-150 bps | Low |
| S05 | LME Activism (Blocking Positions) | Target company loans/bonds | Accumulate >50.1% blocking position to control restructuring outcome and extract value | 500-2000 bps | Very High |
| S06 | Distressed-for-Control via Loans | Distressed loans (fulcrum) | Buy fulcrum debt at 40-60 cents; convert to equity through restructuring; own the company | 3-10x (equity) | Very High |
| S07 | CLO Arbitrage | Discount loans + CLO equity | Loan prices dislocate from CLO equity; buy loans at 90, warehouse, sell to CLO at par | 200-600 bps | High |
| S08 | Recovery Rate Trade | Same-issuer 1st lien + unsecured | Buy senior secured / sell unsecured of same distressed issuer; capture recovery differential | 15-30 pts | High |
| S09 | Covenant Trap Short | CDS or cash short on target | Identify companies approaching covenant breach with no cure; short before technical default | 300-800 bps | High |
| S10 | Compression Trade (BB-CCC) | Long CCC / Short BB (CDX tranches or single-name) | When BB-CCC spread exceeds 500 bps, buy CCC / sell BB; capture reversion to mean | 200-500 bps | Moderate |
Thesis: In stress episodes, the CDX HY index (synthetic) widens faster than the cash bond market (HYG/JNK). This happens because: (1) macro hedgers buy CDX protection quickly, (2) cash bonds have structural selling friction, (3) the CDX is the "first mover" instrument. When the CDX-cash basis exceeds 75 bps, go long cash bonds (buy HYG) and short CDX HY (sell protection). The trade converges as either CDX tightens (stress fades) or cash catches up (bonds sell off). Either way, the basis compresses.
Entry: CDX HY - Cash Spread > 75 bps (currently: ~55 bps, approaching trigger)
Exit: Basis returns to <25 bps, or 90-day time stop
Sizing: DV01-neutral; match CDX notional to HYG duration-equivalent
Risk: Basis can widen further before converging. Max drawdown in March 2020 was -3% before +12% recovery. Requires ability to hold through mark-to-market pain.
Cross-ref: Vol. II Strategy 03 (macro hedge overlay); Vol. III (CLO impact on loan basis)
Thesis: The same company often has both a leveraged loan (floating, senior secured) and a HY bond (fixed, senior unsecured). In efficient markets, the loan should trade at a premium to the bond (reflecting higher seniority and collateral). But in practice, loans can trade cheaper than bonds due to: (1) CLO selling pressure (OC test failures), (2) loan settlement delays making loans less desirable, (3) mark-to-model stale loan pricing.
Trade: When the loan trades at a discount to where it "should" be vs. the bond (based on seniority and recovery analysis), buy the loan and short the bond. The position is credit-neutral (same issuer) and captures the structural mispricing.
Historical example: In Q4 2025, a large media company's 1st lien term loan traded at 88 while its senior unsecured bond traded at 82. Recovery analysis implied the loan should be at 95+ (65% recovery) vs. the bond at 75 (35% recovery). The loan was 7 points cheap on a relative basis. Within 3 months, the loan repriced to 94 and the bond stayed at 80 — generating ~8 points of P&L on the long leg alone.
Thesis: In modern leveraged credit, the creditor who controls the blocking position controls the restructuring. A "blocking position" is ownership of >50.1% of a given tranche (or the relevant amendment threshold, often 66.7% for sacred rights). With a blocking position, you can: (1) veto any amendment that impairs your claim, (2) force the company to negotiate with you, (3) participate in (or prevent) uptier transactions, (4) extract consent fees, new money participation rights, or improved terms.
This is the most powerful strategy in distressed credit but also the most capital-intensive. Building a blocking position in a $500M loan tranche requires $250M+ of capital. This is a strategy for large credit funds (Apollo, Elliott, Oaktree) — but understanding it is essential even for smaller participants, because you need to know when someone ELSE is building a blocking position in your credits. When a single fund crosses 25% ownership in a distressed loan, the LME probability spikes. Track 13D-equivalent filings and LSTA trade reporting for concentration signals.
Thesis: Buy the fulcrum security — the debt tranche that will convert to equity in a restructuring — at distressed prices (40-60 cents). Through the Chapter 11 process or out-of-court exchange, this debt converts to ownership of the reorganized company. If the business is viable, the equity received is worth more than the debt cost.
Fulcrum identification: The fulcrum sits at the point in the capital structure where enterprise value "runs out." If a company has $300M of 1st lien debt and $200M of 2nd lien debt, and enterprise value is $350M, the 1st lien recovers par (100%) and the 2nd lien is the fulcrum — it recovers only 25% in cash but gets the equity. If you buy the 2nd lien at 30 cents and the equity is worth 50 cents on the dollar, you earn 67% return.
Cross-ref: Vol. IV (Distressed Debt Playbook) provides the complete framework for distressed-for-control investing. This volume focuses on the loan execution mechanics. Key loan-specific issue: loan assignment delays in distressed situations can take 20+ business days — if a restructuring support agreement (RSA) has a sign-on deadline, you must start accumulating well in advance.
Thesis: When loan prices drop below 95, CLO equity becomes cheaper to create. A CLO manager can buy loans at 90-95 cents, structure them into a CLO, and issue AAA-rated tranches at par. The 5-10 point discount on the assets vs. the par issuance on the liabilities creates excess subordination and higher equity returns. The trade: buy discounted loans in the secondary market, warehouse them, and sell into new CLO formation ($209B record in 2025). Alternatively, buy CLO equity when loan prices are low (the equity will benefit from pull-to-par as loans season).
Current opportunity: LSTA 100 at 96.2 and new CLO AAA spreads at SOFR+155 create a viable arb. CLO equity returns model to 14-18% IRR at current entry points vs. 10-12% at par. The risk: if loans continue to fall (defaults accelerate), the CLO OC cushion erodes and equity returns can go to zero. This is a bet on "stress, not catastrophe."
Cross-ref: Vol. III (CLO Market Deep Dive) provides the complete CLO structural analysis, waterfall mechanics, and OC test framework.
Thesis: The BB-CCC spread mean-reverts. At 582 bps (current), it is 200 bps wide of the 5-year average (380 bps). Historical pattern: the spread peaks during stress episodes, then compresses violently as (1) CCC credits that survive re-rate, (2) defaults remove the weakest names (survivorship bias tightens CCC spreads), (3) risk appetite returns. Go long a basket of CCC-rated credits that are likely to survive (adequate liquidity, 2+ years to maturity, real assets) and short BB-rated credits that are fully priced.
Entry: BB-CCC spread > 500 bps (currently triggered)
Exit: Spread compresses to <350 bps, or 12-month time stop
Sizing: Spread-duration neutral; underweight CCCs by notional (wider spreads = more DV01 per dollar)
Historical: This trade returned 800-1200 bps in the 12 months after the March 2020 wides and 600-900 bps after the 2016 energy stress peak.
The 15 most common LME structures that define modern credit restructuring. Creditor-on-creditor violence is no longer an edge case — it is the default playbook for every large leveraged borrower under stress. If you hold leveraged credit, you must know these structures.
LMEs have fundamentally changed the risk/reward of holding leveraged credit. In the pre-LME era (before ~2018), creditors could rely on pari passu treatment and pro-rata sharing. Today, a borrower (with sponsor support) can use the flexibility embedded in credit agreements to transfer value from one group of creditors to another — legally. The creditors who understand these structures profit. The creditors who don't get primed, dropped, or left holding impaired paper. Every major restructuring in 2025-2026 has used at least one of these 15 structures.
| # | LME Structure | Mechanism | Who Gets Hurt | Precedent |
|---|---|---|---|---|
| L01 | Uptier Priming | Majority lenders agree to elevate their claims to super-priority, subordinating the minority | Minority holdout lenders — primed below the new super-senior tranche | Serta Simmons (2020), Boardriders (2020) |
| L02 | Drop-Down | Borrower transfers valuable assets to an unrestricted subsidiary, then issues new debt at that subsidiary secured by those assets | Existing creditors — collateral value moves beyond their reach | J.Crew (2017 — IP transfer), PetSmart/Chewy |
| L03 | Double-Dip | New debt gets claims at two levels of the capital structure: both as a direct obligation and through an intercompany claim (structural doubling) | Existing unsecured creditors — recovery pool diluted by the double claim | Envision Healthcare (2023), Incora |
| L04 | Cooperative Exchange | Select group of creditors offers fresh capital in exchange for improved priority, with borrower's cooperation | Non-participating creditors — left with subordinated or impaired claims | Revlon (2020), Plurilock (2024) |
| L05 | Non-Pro-Rata Exchange | Borrower offers exchange terms to selected creditors only, violating the spirit (but exploiting loopholes in) pro-rata sharing provisions | Excluded creditors — stuck with original (now inferior) terms | TriMark (2020), Mitel Networks |
| L06 | J.Crew Maneuver | Transfer of intellectual property (brand, trademarks) to unrestricted subsidiary to be used as collateral for new financing | Secured creditors — collateral base shrinks as IP is removed | J.Crew (2017) — the original template |
| L07 | Serta Maneuver | Majority lenders consent to new super-priority tranche funded by themselves, priming the minority without their consent | Minority lenders — structurally subordinated without voting | Serta Simmons (2020) — litigated extensively |
| L08 | Pari-Plus / Priority Layering | New debt issued at same collateral pool but with contractual priority of payment over existing pari passu debt | Existing pari passu holders — effectively subordinated | Multiple 2024-2025 restructurings |
| L09 | Extend & Pretend | Maturity extended, amortization reduced, PIK toggle activated — no debt reduction, just deferral | All creditors long-term — NPV of claims reduced even if face value preserved | Widespread in 2024-2026 sponsor-backed credits |
| L10 | Debt-for-Equity Swap | Creditors exchange debt claims for equity in the reorganized entity, usually at a significant discount | Junior creditors and equity — diluted or wiped out | Standard Ch. 11 mechanism |
| L11 | Credit Bid | Secured creditors bid their debt claims (at face value) to acquire assets in a Section 363 sale, outbidding cash buyers | Unsecured creditors and equity — assets transferred at face, leaving less for junior claims | Common in distressed asset sales |
| L12 | DIP-to-Exit Financing | Debtor-in-possession lender structures DIP loan to convert to exit facility, controlling the post-reorg capital structure | Existing lenders not participating in DIP — their claims are repaid at plan recovery, not par | Standard for controlled restructurings |
| L13 | Inter-Creditor Agreement Exploit | Exploiting ambiguities in intercreditor agreements to assert priority not originally intended by the parties | Creditors on the wrong side of the intercreditor language — litigation ensues | iHeart Media, Windstream |
| L14 | Covenant Stripping via Amendment | Majority lenders consent to strip protective covenants in exchange for a fee, enabling borrower to take value-destructive actions | Minority lenders and all creditors long-term — protections removed for a small upfront fee | Common in 2023-2025 amendment wave |
| L15 | Liability Management Kill Zone | Combination of multiple LME techniques in sequence (e.g., drop-down + uptier + non-pro-rata exchange) to maximize value extraction | Any creditor not in the "coalition of the willing" — multi-vector attack on claims | Envision, Incora, At Home Group |
How it works, step by step:
1. Company X has $1B in first-lien term loans held by 50 lenders. The credit agreement requires simple majority (50.1%) for most amendments.
2. The company approaches a coalition of lenders holding 51%+ of the outstanding loans. It offers them: "Participate in a new $400M super-priority facility. Your existing loans get exchanged into this new tranche at par + a consent fee. The new tranche will have first-out priority in the collateral waterfall."
3. The 51% coalition votes to amend the credit agreement to permit the new super-priority tranche. The amendment passes.
4. The minority lenders (49%) still hold their original first-lien loans — but now there is a $400M super-priority tranche sitting ABOVE them in the waterfall. Their effective recovery has dropped from 65 cents to 30-40 cents.
5. The minority lenders sue. Litigation ensues for 2-3 years. In the meantime, the company uses the new $400M to continue operations. The minority either settles at a discount or litigates while their claims deteriorate further.
Defense: (a) Accumulate a blocking position >50.1% so you cannot be primed, (b) monitor ownership concentration — when a single fund crosses 25%, they may be building a priming coalition, (c) read the credit agreement amendment provisions carefully — some require supermajority (66.7%) for lien priority changes.
The drop-down exploits the "unrestricted subsidiary" designation in credit agreements. Most leveraged loan credit agreements allow the borrower to designate certain subsidiaries as "unrestricted," meaning they are outside the credit group (not guarantors, not subject to covenants). The borrower transfers valuable assets (IP, real estate, operating subsidiaries) to an unrestricted subsidiary. Then it issues new debt at the unrestricted subsidiary, secured by those assets. The existing creditors' collateral base has shrunk. The new creditors at the unrestricted sub have first claim on the transferred assets.
J.Crew pioneered this in 2017 by transferring its trademark and intellectual property — the most valuable assets in a retail business — to an unrestricted Cayman Islands subsidiary. It then used the IP as collateral for new financing. Existing creditors were left with claims on an operating company that no longer owned its own brand. The "permitted investment" and "unrestricted subsidiary" baskets in the credit agreement are the sections that enable this. If these baskets are large and loosely defined, the drop-down risk is high.
How to construct a leveraged credit portfolio that balances carry, convexity, and tail risk. The framework applies whether you are running a loan fund, a HY mandate, or a multi-asset credit book.
| Allocation | Target Weight | Instrument | Role | Current Positioning |
|---|---|---|---|---|
| Core Carry | 40-50% | BB-rated loans and bonds | Stable income, low default risk | Overweight — quality in stress |
| Opportunistic | 15-25% | Dislocated single names, new issue | Alpha generation, basis trades | Increasing — dislocations emerging |
| Distressed / Special Sits | 5-15% | Loans <80, LME targets, fulcrum | Convexity, restructuring upside | Building — defaults rising |
| Hedges | 10-20% | CDX HY protection, HYG puts | Tail risk, negative carry offset | Full allocation — elevated risk |
| Liquid Buffer | 5-10% | Cash, T-Bills, IG ETFs | Dry powder for dislocation | At max — waiting for wider levels |
The cardinal rule of leveraged credit portfolio construction: never be a forced seller. Leveraged loans settle T+7-20. Distressed loans can take 30+ days. If you run a daily-liquidity fund holding illiquid loans, you WILL be a forced seller in a stress event — and forced sellers in credit markets receive the worst prices. This is why: (1) CLO equity (locked-up, 5-year reinvestment) can earn higher returns than loan mutual funds (daily liquidity) holding the same assets, (2) the "gates" in private credit funds (Vol. II) are a feature, not a bug, for the manager, and (3) the liquid buffer in the portfolio above is non-negotiable. In credit, the ability to wait is the primary source of alpha.
Position sizing in distressed credit follows a different logic than in performing credit. In performing credit, you size by spread duration (DV01). In distressed credit, you size by recovery analysis. A $10M position in a loan at 45 cents with expected recovery of 65 cents has $2M of upside and $4.5M of downside (to zero). The asymmetry is unfavorable unless you have (a) high conviction in the recovery analysis, (b) a blocking position that gives you control over the outcome, or (c) a portfolio of 15-20 distressed positions where the winners more than compensate for the zeros. Never concentrate in a single distressed name without control.
Where to get the data that drives the desk. Pricing, index levels, CLO analytics, credit agreement repositories, and trade flow. Most are institutional-only, but several have free tiers or alternatives.
| Source | Coverage | Access | Cost | Key Use |
|---|---|---|---|---|
| LSTA / Refinitiv LPC | Leveraged loan pricing, volumes, new issue | Institutional | $$$$ | Primary loan data source |
| Markit (S&P Global) | CDS spreads, CDX levels, loan marks | Institutional | $$$$ | CDS/CDX pricing, consensus marks |
| TRACE (FINRA) | HY bond trade prices, volumes | Free (delayed) / $$ (real-time) | Free/$ | Bond price transparency |
| Bloomberg Terminal | Everything — bonds, loans, CDS, CLOs | Institutional | $$$$ | Primary trading terminal |
| Intex / Moody's Analytics | CLO structure, waterfall modeling | Institutional | $$$ | CLO cash flow analysis (Vol. III) |
| Covenant Review (Fitch) | Credit agreement analysis, covenant scoring | Institutional | $$$ | LME risk assessment, doc review |
| Reorg Research | Restructuring situations, LME tracking | Institutional | $$$ | Distressed situations, RSA tracking |
| PitchBook / LCD | Leveraged loan issuance, terms, spreads | Institutional | $$$ | Primary market intelligence |
| FRED (St. Louis Fed) | ICE BofA HY index OAS, default rates | Free | Free | Macro credit spreads, historical data |
| SEC EDGAR | Credit agreements, 10-K/Q filings, 13D | Free | Free | Document source for credit analysis |
The free data stack for credit analysis: You don't need a Bloomberg terminal to do credit work. FRED provides HY OAS, default rates, and spread history. TRACE provides bond prices (15-minute delay is free via FINRA). SEC EDGAR has every credit agreement, indenture, and financial filing. LSTA publishes quarterly market statistics. ICE BofA publishes index returns monthly. Combine FRED + TRACE + EDGAR + a spreadsheet and you can replicate 80% of what a $25,000/year Bloomberg terminal provides for credit analysis. The remaining 20% (real-time CDX levels, consensus loan marks, CLO waterfall models) is what you pay for.
The most common mistakes in leveraged credit trading. Each one has destroyed P&L for professionals. They are listed in order of how frequently they occur.
| # | Pitfall | What Happens | How to Avoid |
|---|---|---|---|
| P01 | Ignoring Settlement Risk in Loans | You buy a loan at 85. Settlement takes 18 days. A negative event drops the loan to 70 before settlement. You're locked into the trade at 85. | Price in settlement delay. Use settlement contingency language. Size for delay. |
| P02 | Trusting Adjusted EBITDA | Company reports 4.5x leverage on "Adjusted EBITDA" with $200M of add-backs. Real cash EBITDA puts leverage at 7x. You bought based on 4.5x. | Always calculate leverage on unadjusted EBITDA. Subtract add-backs. Compare to cash flow. |
| P03 | Missing LME Vulnerability | You hold a loan with strong fundamentals but a credit agreement with loose "unrestricted subsidiary" baskets. The company does a drop-down. Your collateral evaporates. | Read the credit agreement. Score LME risk using Covenant Review or internal framework. |
| P04 | Assuming Pari Passu Means Equal | You hold pari passu unsecured bonds. A cooperative exchange gives 60% of bondholders a new secured tranche. You're left with impaired unsecured claims. | Monitor ownership concentration. Join creditor groups early. Hold blocking positions. |
| P05 | Reaching for Yield in CCCs | A CCC bond yields 14%. You buy for the carry. Six months later it defaults and you recover 25 cents. Your "14% yield" was actually -61% total return. | Never buy CCCs for yield alone. Analyze: can this company service debt for 3+ years? If uncertain, the yield is compensation for loss, not income. |
| P06 | Ignoring CLO Technicals | A loan is "cheap" at 88. But CLOs are the marginal buyer, and CLOs are in OC test failure mode (Vol. III). No one is buying. The loan goes to 78. | Track CLO OC test cushions, BWIC volumes, and CLO formation ($209B record in 2025) rates. If CLOs can't buy, who will? |
| P07 | Misidentifying the Fulcrum | You buy second-lien debt at 40 cents thinking it's the fulcrum. Enterprise value drops further. First-lien takes all the recovery. Second-lien recovers 5 cents. | Enterprise value analysis with multiple scenarios. Sensitivity-test to -20% and -40% EV haircuts. |
| P08 | Basis Blowout (Being Early) | You put on the CDX-cash basis trade at 60 bps. The basis widens to 150 bps. You get a margin call and are forced to unwind at the worst level. | Size for basis to double before converging. Never lever basis trades more than 3x. Have committed capital. |
The single most expensive mistake in leveraged credit: confusing yield with return. A CCC-rated loan yielding 12% with a 15% annual default probability and 30% recovery rate has an expected return of: (0.85 x 12%) + (0.15 x -70%) = 10.2% - 10.5% = -0.3% expected return. The "yield" is an illusion — it is compensation for expected loss, not excess return. Real alpha in credit comes from: (1) avoiding defaults (selection), (2) capturing basis (relative value), (3) controlling restructurings (activism), and (4) buying dislocations (timing). Carry alone is not a strategy — it is a risk premium.
What to monitor daily, weekly, and monthly to stay ahead of regime changes in leveraged credit. This is your early warning system.
| Frequency | Metric | Source | Trigger Level | Signal |
|---|---|---|---|---|
| Daily | CDX HY Spread | Bloomberg / Markit | >500 bps = stress | Macro credit risk-off |
| Daily | HYG NAV Premium/Discount | ETF provider / Bloomberg | >1% discount = selling pressure | Retail outflows, forced liquidation |
| Daily | BKLN NAV Premium/Discount | ETF provider / Bloomberg | >2% discount = loan stress | Loan liquidity drying up |
| Weekly | BWIC Volume (by rating) | Dealer desks / LSTA | 2x normal = forced selling | CLO OC test failures triggering sales |
| Weekly | New Issue Spread (vs. secondary) | LCD / PitchBook | Concession >50 bps = weak demand | Primary market tightening |
| Weekly | Fund Flows (HY + Loan funds) | Lipper / EPFR | >$2B weekly outflow = stress | Retail capitulation indicator |
| Monthly | Default Rate (trailing 12M) | Moody's / S&P / LSTA | >3.5% = elevated | Fundamental credit deterioration |
| Monthly | CLO Formation Volume | LCD / CLO-i | <$8B/month = demand gap | Loan demand shrinking |
| Monthly | BB-CCC Spread | ICE BofA / FRED | >500 bps = quality bifurcation | Dispersion regime active |
| Monthly | Recovery Rates (1st Lien) | Moody's Ultimate Recovery | <60% = LME-compressed | Restructuring regime change |
| Quarterly | Distress Ratio (Loans <80) | LSTA / LCD | >7% = default pipeline building | 6-12 month forward default indicator |
| Quarterly | CLO OC Test Cushion (avg) | Intex / Moody's | <3% avg = systemic CLO risk | CLO forced selling imminent (Vol. III) |
The four-signal confluence that predicts a credit regime change: When ALL four of these occur simultaneously, a major credit stress event is either imminent or already underway: (1) CDX HY > 500 bps, (2) HYG discount > 2%, (3) weekly HY fund outflows > $3B, (4) distress ratio > 8%. As of April 2026, three of four signals are active. CDX HY at 412 bps is the holdout — if it crosses 500, the full confluence is triggered. At that point: max hedge allocation, max liquid buffer, and prepare capital for the dislocation purchases that follow every stress episode. Cross-ref: Vol. II provides the strategic overlay for this positioning; this volume provides the instruments and execution.
This document is Volume X in a 12-volume series of institutional-grade market intelligence briefings covering private markets, alternative credit, insurance, banking, sovereign debt, and volatility strategies.